Fundz

Xeris Pharmaceuticals Inc reported raising $41 Million in an initial SEC Form D filing, from an offering of $50 Million

PUBLIC · XERSJan 11, 2016$41M of $50M raised

Amount Raised

$41 Million

$41 Million sold, per SEC Form D (first sale Jan 11, 2016)

Round Type

Venture

ChicagoBiotechnologyHealthcareHealth CareBiopharma

Quick answer

Xeris Biopharma Holdings raised $41 Million in a funding round, dated January 11, 2016. Xeris Biopharma Holdings is based in Chicago, Illinois, United States.

How much did Xeris Biopharma Holdings raise?
Xeris Biopharma Holdings raised $41 Million in a funding round on January 11, 2016.
What does Xeris Biopharma Holdings do?
Xeris Biopharma Holdings, Inc. is a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies.
Where is Xeris Biopharma Holdings based and how big is it?
Xeris Biopharma Holdings is based in Chicago, Illinois, United States. Fundz records about 400 employees.

Source: Fundz verified event record.

Who else raised in Healthcare and Biopharma around the same time

Companies in the same sectors as Xeris Biopharma Holdings that raised within 45 days of this round, from Fundz verified event records.

Who to call at Xeris Biopharma Holdings, and when

A new round usually means Xeris Biopharma Holdings is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Xeris Biopharma Holdings raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Xeris Biopharma Holdings, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Xeris Biopharma Holdings. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Xeris Biopharma Holdings

Location

Chicago, Illinois, United States

About

Xeris Biopharma Holdings, Inc. is a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Xeris Biopharma Holdings raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Xeris Biopharma Holdings's next move

See what Strategic adds

Xeris Biopharma Holdings raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.